$TNFA accumulation has been significant at these levels. They are holding it in place with high frequency.
They have warrant coverage higher, and are on the NASDAQ’s radar for price. Most importantly a short north of 32%. This thing is coiled up, it needs the spark. Management, don’t screw it up!
Time to send this north, far too much to be sitting at $.10 with two drugs in clinical trials and 14.17m float.
Not a recommendation, do your own due diligence and see what I see!
$TNFA Excitement is building for the next upcoming update. TNFA has been working on these game changing projects these last few months and updates are imminent.
$TNFA over 100m traded pre-market on 14.17m float. It hit pre-market at $.15!
It is time for the company to bring the final nail to these shorts. Huge upside, phase 2b clinical trials. Over 30% short position and this thing is coiled up ready to explode...
Is this stock the next $IXHL? It has the formula for a $.09-$1.00+ move, can the company make it happen?
Too much meat on the bone here IMO!!!
$tnfa
From their website
"The company is now planning to initiate Phase 3 trials. If approved, MYMD-1® has the potential to be the first drug approved by FDA for the sarcopenia..."
@stockplaymaker1 The squeeze potential of $TNFA is huge. The DD is huge. And stock is already on full bullish alert. Watching for upward movement PM. 👀
$TNFA not just sitting here posting on a potential runner. I’m for just over 600k shares total currently, down a bit but they aren’t scaring me outa my position!
Too much potential here with clinical trials, 14m share float with 2.5 billion shs traded in last month, over 32% short position and overhanging warrant coverage at $.364
I’ve placed my wager that $TNFA rolls hard 🤌🏼���💴